Sign in

CIK 0001427925

  • Non-accelerated filer
  • Smaller reporting company

TALPHERA, INC.

Sign in to watch
Ticker
TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412193603
Phone
+1 650-216-3500
Business address
1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
Former names
ACELRX PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-20 Aslam Shakil Chief Medical Officer Shares withheld for taxes −4,518 $0.82 $4K 76,542
2026-04-02 Aslam Shakil Chief Medical Officer Shares withheld for taxes −2,118 $0.72 $2K 81,060
2026-02-12 Aslam Shakil Chief Medical Officer Purchase +35,000 $0.81 $28K 83,178
2026-02-12 Aslam Shakil Chief Medical Officer Grant or award · Stock Option (Right to Buy) +205,000 205,000
2025-05-20 Aslam Shakil Chief Medical Officer Shares withheld for taxes −4,517 $0.52 $2K 48,178
2025-04-02 Aslam Shakil Chief Medical Officer Grant or award +15,000 52,695
2025-04-02 Aslam Shakil Chief Medical Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2024-06-14 Aslam Shakil Chief Medical Officer Purchase +5,000 $1.07 $5K 37,695
2024-06-13 Aslam Shakil Chief Medical Officer Purchase +695 $0.98 $681 32,695

Page 1 of 1 · 9 trades